Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment

Current Drug Targets

Volumn 12, Issue 8, 2011, Pages 1166-1186

  Rosenholm, Jessica M ^a,b   Sahlgren, Cecilia ^a,c   Lindén, Mika ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Drug delivery systems; Gene delivery; Mesoporous silica nanoparticles (MSNs); Multidrug resistance; Multimodal imaging; Photodynamic therapy; Targeted cancer therapy; Theragnostic agents

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; CETRIMIDE; CYTOCHROME C; DRUG VEHICLE; GOLD; GREEN FLUORESCENT PROTEIN; IRON OXIDE; ITRACONAZOLE; LYSOZYME; MACROGOL; NANOPARTICLE; PAPAIN; PHOSPHATE BUFFERED SALINE; PHOTOSENSITIZING AGENT; PLATINUM; POLIDOCANOL; POLOXAMER; POLY(N ISOPROPYLACRYLAMIDE); POLYGLACTIN; QUANTUM DOT; SILICON DIOXIDE; SMALL MOLECULE TRANSPORT AGENT; SODIUM CHLORIDE; SUPERPARAMAGNETIC IRON OXIDE; TRYPSIN;

BODY SURFACE; CELL SPECIFICITY; CERAMICS; DIAGNOSTIC IMAGING; DRUG TARGETING; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH; REDOX STRESS; REVIEW; X RAY DIFFRACTION;

DIAGNOSTIC IMAGING; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; MOLECULAR TARGETED THERAPY; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; POROSITY; SILICON DIOXIDE;

EID: 79959313919     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011795906624     Document Type: Review

References (168)

1. Liversidge G. Merisko-Liversidge E. Ruddy SB. Callanan, F. Will nanoparticles deliver? Drug Discov Develop 2009; 12: 30-4.
2. Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomed Nanotech Biol Med 2007; 3: 20-31.
3. Hartmann M. Ordered mesoporous materials for bioadsorption and biocatalysis. Chem Mater 2005; 17: 4577-93.
4. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007; 46: 7548-58.
5. Avnir D, Coradin T, Lev O, Livage, J. Recent bio-applications of sol-gel materials. J Mater Chem 2006; 16: 1013-30.
6. Trewyn BG, Giri S, Slowing II, Lin, VSY. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun 2007; 3236-45.
7. Giri S, Trewyn BG, Lin VSY. Mesoporous silica nanomaterialbased biotechnological and biomedical delivery systems. Nanomedicine 2007; 2: 99-111.
8. Slowing, II, Trewyn, BG.; Giri, S, Lin VSY. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 2007; 17: 1225-36.
9. Trewyn, BG, Slowing, II, Giri S, Chen HT, Lin VSY. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res 2007; 40: 846-53.
10. Slowing II, Vivero-Escoto L, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008; 60: 1278-88.
11. Angelos S, Liong M, Choi E, Zink, JI. Mesoporous silicate materials as substrates for molecular machines and drug delivery. Chem Eng J 2008; 137: 4-13.
12. Liong M, Angelos S, Choi E, Patel K, Stoddart JF, Zink JI. Mesostructured multifunctional nanoparticles for imaging and drug delivery. J Mater Chem 2009; 19: 6251-7.
13. Pasqua L, Cundari S, Ceresa C, Cavaletti G. Recent development, applications, and perspectives of mesoporous silica particles in medicine and biotechnology. Curr Med Chem 2009; 16: 3054-63.
14. Wang SB. Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater 2009; 117: 1-7.
15. Rosenholm J, Sahlgren C, Lindén M. Cancer-cell targeting and cellspecific delivery by mesoporous silica nanoparticles. J Mater Chem 2010; 20: 2707-13.
16. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC. Ordered mesoporous molecular-sieves synthesized by a liquid-crystal template mechanism. Nature 1992; 359: 710-2.
17. Beck JS, Vartuli JC, Roth WJ, et al. A new family of mesoporous molecular-sieves prepared with liquid-crystal templates. J Am Chem Soc 1992; 114: 10834-43.
18. Yanagisawa T, Shimizu T, Kuroda K, Kato C. The preparation of alkyltrimethylammonium-kanemite complexes and their conversion to microporous materials. Bull Chem Soc Jpn 1990; 63: 988-92.
19. For examples of MSN synthesis, see for instance: Urata C, Aoyama Y, Tonegawa A, Yamauchia Y, Kuroda K. Chem Commun 2009; 5094-6, and references therein.
20. Berggren A, Holmberg K, Palmqvist AEC. Synthesis of stable colloidal suspensions of ordered mesostructured silica from sodium metasilicate using pluronic P123 and mildly acidic conditions. Stud Surf Sci Catal 2007; 165: 53-6.
21. He Q, Cui X, Cui F, Guo L, Shi J. Size-controlled synthesis of monodispersed mesoporous silica nano-spheres under a neutral condition Microporous Mesoporous Mater 2009; 117: 609-16.
22. Kapoor MP, Fujii W, Yanagi M, et al. Environmental friendly rapid mass production synthetic process of highly ordered nanometer sized mesoporous silica using a combination of acid-base and evaporation approach. Microporous Mesoporous Mater 2008; 116: 370-7.
23. Lin KJ, Chen LJ, Prasad MR, Cheng CY. Core-shell synthesis of a novel, spherical, mesoporous silica/platinum nanocomposite: Pt/PVP@MCM-41. Adv Mater 2004; 16: 1845-9.
24. Joo SH, Park JY, Tsung CK, Yamada Y, Yang P, Somorjai GA. Thermally stable Pt/mesoporous silica core-shell nanocatalysts for high-temperature reactions. Nature Mater 2009; 8: 126-31.
25. Nooney RI, Dhanasekaran, T, Chen Y, Josephs R, Ostafin AE. Selfassembled highly ordered spherical mesoporous silica/gold nanocomposites. Adv Mater 2002; 14: 529-32.
26. Nooney RI, Thirunavukkarasu D, Chen Y, Josephs R, Ostafin AE. Self-assembly of mesoporous nanoscale silica/gold composites. Langmuir 2003; 19: 7628-37.
27. Gorelikov I, Matsuura N. Single-step coating of mesoporous silica on cetyltrimethyl ammonium bromide-capped nanoparticles. Nano Lett 2008; 8: 369-73.
28. Fan H, Gabaldon J, Brinker CJ, Jiang YB. Ordered nanocrystal/ silica particles self-assembled from nanocrystal micelles and silicate. Chem Commun 2006; 2323-5.
29. Botella P, Corma A, Navarro MT. Single gold nanoparticles encapsulated in monodispersed regular spheres of mesostructured silica produced by pseudomorphic transformation. Chem Mater 2007; 19: 1979-83.
30. Jiang X, Brinker CJ. Aerosol-assisted self-assembly of singlecrystal core/nanoporous shell particles as model controlled release capsules. J Am Chem Soc 2006; 128: 4512-3.
31. Kim J, Lee JE, Lee J, et al. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc 2006; 128: 688-9.
32. Liong M, France B, Bradley KA, Zink JI. Antimicrobial Activity of Silver Nanocrystals Encapsulated in Mesoporous Silica Nanoparticles. Adv Mater 2009; 21: 1684-9.
33. 2 nanocomposites with diverse mesostructures. J Colloid Interface Sci 2008; 326: 158-65.
34. Kim J, Kim HS, Lee N, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008; 47: 8438-41.
35. Lin YS, Haynes CL. Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles. Chem Mater 2009; 21: 3979-86.
36. Wu P, Zhu J, Xu Z. Template-assisted synthesis of mesoporous magnetic nanocomposite particles. Adv Funct Mater 2004; 14: 345-51.
37. Zhao W, Gu J, Zhang L, Chen H, Shi J. Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure. J Am Chem Soc 2005; 127: 8916-7.
38. 2 shell for removal of microcystins. J Am Chem Soc 2008; 130: 28-9.
39. Zhao W, Shi J, Chen H, Zhang L. Particle size, uniformity, and mesostructure control of magnetic core/mesoporous silica shell nanocomposite spheres. J Mater Res 2006; 21: 3080-9.
40. Stöber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in micron size range. J Colloid Interface Sci 1968; 26: 62-9.
41. Graf C, van Blaaderen A. Metallodielectric colloidal core-shell particles for photonic applications. Langmuir 2002; 18: 524-32.
42. Yoon SB, Kim JY, Kim JH, et al. Synthesis of monodisperse spherical silica particles with solid core and mesoporous shell: mesopore channels perpendicular to the surface. J Mater Chem 2007; 17: 1758-61.
43. Kim JH, Yoon SB, Kim JY, Chae YB, Yu JS. Synthesis of monodisperse silica spheres with solid core and mesoporous shell: Morphological control of mesopores. Colloids Surf A Physicochem Eng Aspects 2008; 313-314: 77-81.
44. Nakamura T, Mizutani M, Nozaki H, Suzuki N, Yano K. Formation mechanism for monodispersed mesoporous silica spheres and its application to the synthesis of core/shell particles. J Phys Chem C 2007; 111: 1093-100.
45. For a recent review, see for instance: Athens GL, Shayib RM, Chmelka BF. Functionalization of mesostructured inorganicorganic and porous inorganic materials. Curr Opin Colloids Interface Sci 2009; 14: 281-92.
46. Che S, Garcia-Bennett AE, Yokoi T, et al. A novel anionic surfactant templating route for synthesizing mesoporous silica with unique structure. Nat Mater 2003; 2: 801-5.
47. de Juan F, Ruiz-Hitzky E. Selective functionalization of mesoporous silica. Adv Mater 2000; 12: 430-2.
48. Rosenholm JM, Duchanoy A, Lindén M. Hyperbranching surface polymerization as a tool for preferential functionalization of the outer surface of mesoporous silica. Chem Mater 2008; 20: 1126-33.
49. Kecht J, Schlossbauer A, Bein T. Selective Functionalization of the Outer and Inner Surfaces in Mesoporous Silica Nanoparticles. Chem Mater 2008; 20: 7207-14.
50. He Q, Zhang J, Shi J, et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010; 31:1085-92.
51. Huang S, Fan Y, Cheng Z, et al. Magnetic mesoporous silica spheres for drug targeting and controlled release. J Phys Chem C 2009; 113: 1775-84.
52. Zhu Y, Shi J, Shen W, et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angew Chem Int Ed 2005; 44: 5083-7.
53. Zhu Y, Shi J. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Microporous Mesoporous Mater 2007; 103: 243-9.
54. You YZ, Kalebaila KK, Brock SL, Oupický D. Temperaturecontrolled uptake and release in PNIPAM-modified porous silica nanoparticles. Chem Mater 2008; 20: 3354-9.
55. Zhu S, Zhou Z, Zhang D. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles. ChemPhysChem 2007; 8: 2478-83.
56. Lim MH, Stein A. Comparative studies of grafting and direct syntheses of inorganic-organic hybrid mesoporous materials. Chem Mater 1999; 11: 3285-95.
57. Zhuravlev LT. Surface characterization of amorphous silica - a review of work from the former USSR. Colloids Surf A Physicochem Eng Aspects 1993; 74: 71-90.
58. Iler RK. The Chemistry of Silica, Wiley, New York 1979.
59. Rosenholm JM, Lindén M. Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J Control Release 2008; 128: 157-64.
60. Tang Q, Xua Y, Wua D, Sun Y. A study of carboxylic-modified mesoporous silica in controlled delivery for drug famotidine. J Solid State Chem 2006; 179: 1513-20.
61. Hartmann M. Ordered mesoporous materials for bioadsorption and biocatalysis. Chem Mater 2005; 17: 4577-93.
62. Hudson S, Magner E, Cooney J. Proteins in mesoporous silicates. Angew Chem Int Ed 2008; 47: 8582-94.
63. Diaz JF, Balkus KF Jr. Enzyme immobilization in MCM-41 molecular sieve. J Mol Catal B 1996; 2: 115-26.
64. Deere J, Magner E, Wall JG, Hodnett BK. Adsorption and activity of cytochrome c on mesoporous silicates. Chem Commun 2001; 465-6.
65. Deere J, Magner E, Wall JG, Hodnett BK. Adsorption of cytochrome c onto ordered mesoporous silicates. Stud Surf Sci Catal 2001; 135: 233.
66. Vinu A, Murugesan V, Tangermann O, Hartmann M. Adsorption of cytochrome c on mesoporous molecular sieves: influence of ph, pore diameter, and aluminum incorporation. Chem Mater 2004; 16: 3056-65.
67. Vinu, A, Murugesan V, Tangermann O, Hartmann M. Adsorption of lysozyme over mesoporous molecular sieves mcm-41 and sba-15: influence of ph and aluminum incorporation. J Phys Chem B 2004; 108: 7323-30.
68. Lu S, He J, Guo X. Architecture and performance of mesoporous silica-lipase hybrids via non-covalent interfacial adsorption. AICHE J 2010; 56: 506-14.
69. Han Y-J, Stucky GD, Butler A. Mesoporous silicate sequestration and release of proteins. J Am Chem Soc 1999; 121: 9897-8.
70. Slowing II, Trewyn BG, Lin VS-Y. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 2007; 129: 8845-9.
71. Solberg SM, Landry CC. Adsorption of DNA into mesoporous silica. J Phys Chem B 2006; 110: 15261-8.
72. Xia T, Kovochich M, Liong M, et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009; 3: 3273-86.
73. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of mcm-41: drug delivery system. Chem Mater 2001; 13: 308-11.
74. Andersson J, Rosenholm J, Areva S, Lindén M. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater 2004; 16: 4160-7.
75. Aiello R, Cavallaro G, Giammona G, Pasqua L, Pierro P, Testa F. Mesoporous silicate as matrix for drug delivery systems of nonsteroidal antinflammatory drugs. Stud Surf Sci Catal 2002; 142: 1165-72.
76. Hata H, Saeki S, Kimura T, Sugahara Y, Kuroda K. Adsorption of taxol into ordered mesoporous silicas with various pore diameters. Chem Mater 1999; 11: 1110-9.
77. Domingo C, García-Carmona J, Fanovich MA, Saurina J. Study of adsorption processes of model drugs at supercritical conditions using partial least squares regression. Anal Chim Acta 2002; 452: 311-9.
78. Belhadj-Ahmed F, Badens E, Llewellyn P, Denoyel R, Charbit G. Impregnation of vitamin E acetate on silica mesoporous phases using supercritical carbon dioxide. J Supercritical Fluids 2009; 51: 278-86.
79. Hillerström A, van Stam J, Andersson M. Ibuprofen loading into mesostructured silica using liquid carbon dioxide as a solvent. Green Chem 2009; 11: 662-7.
80. Ritter H, Brühwiler D. Accessibility of amino groups in postsynthetically modified mesoporous silica. J Phys Chem C 2009; 113: 10667-74.
81. Tourné-Péteilh C, Brunel D, Bégu S, et al. Synthesis and characterisation of ibuprofen-anchored MCM-41 silica and silica gel. New J Chem 2003; 27: 1415-8.
82. Mortera R, Vivero-Escoto J, Slowing II, Garrone E, Onida B, Lin VS-Y. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system. Chem Commun 2009; 3219-21.
83. Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson J-E, Sahlgren C, Lindén M. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 2010; 6: 1234-41.
84. Carino IS, Pasqua L, Testa F, et al. Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv 2007; 14: 491-5.
85. Mellaerts R, Jammaer JAG, van Speybroeck M, et al. physical state of poorly water soluble therapeutic molecules loaded into sba-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen. Langmuir 2008; 24: 8651-9.
86. Rosenholm JM, Peuhu E, Eriksson JE, Sahlgren C, Lindén M. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. Nano Lett 2009; 9: 3308-11.
87. Chen AM, Zhang M, Wei D, et al. Co-delivery of doxorubicin and Bcl-2 sirna by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 2009; 5: 2673-7.
88. Zhao Y, Trewyn BG, Slowing II, Lin VS-Y. Mesoporous silica nanoparticle-based double drug delivery system for glucoseresponsive controlled release of insulin and cyclic AMP. J Am Chem Soc 2009; 131: 8398-400.
89. Ng JBS, Kamali-Zare P, Brismar H, Bergström L. Release and molecular transport of cationic and anionic fluorescent molecules in mesoporous silica spheres. Langmuir 2008; 24: 11096-102.
90. Cheng K, Landry CC. Diffusion-based deprotection in mesoporous materials: a strategy for differential functionalization of porous silica particles. J Am Chem Soc 2007; 129: 9674-85.
91. Lebold T, Jung C, Michaelis J, Bräuchle C. Nanostructured silica materials as drug-delivery systems for doxorubicin: single molecule and cellular studies. ACS Nano 2009; 9: 2877-83.
92. Cauda V, Muhlstein L, Onida B, Bein T. Tuning drug uptake and release rates through different morphologies and pore diameters of confined mesoporous silica. Microporous Mesoporous Mater 2009; 118: 435-42.
93. Cauda C, Schlossbauer A, Bein T. Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol). Microporous Mesoporous Mater 2010; 132: 60-71.
94. Mortera R, Fiorilli S, Garrone E, Verné E, Onida B. Pores occlusion in MCM-41 spheres immersed in SBF and the effect on ibuprofen delivery kinetics: A quantitative model. Chem Eng J 2010; 156: 184-92.
95. Ng JBS, Kamali-Zare P, Sörensen M, Brismar H, Hedin N, Bergström L. Intraparticle transport and release of dextran in silica spheres with cylindrical mesopores. Langmuir 2010; 26: 466-70.
96. Cauda V, Onida B, Platschek B, Mühlstein L, Bein T. Large antibiotic molecule diffusion in confined mesoporous silica with controlled morphology. J Mater Chem 2008; 18: 5888-99.
97. Cotí KK, Belowich ME, Liong M, et al. Mechanised nanoparticles for drug delivery. Nanoscale 2009; 1: 16-39.
98. Aznar E, Martínez-Mañez R, Sancenón F. Controlled release using mesoporous materials containing gate-like scaffoldings. Exp Op Drug Deliv 2009; 6: 643-55.
99. Casasús R, Marcos MD, Martínez-Máñez R, et al. Toward the development of ionically controlled nanoscopic molecular gates. J Am Chem Soc 2004; 126: 8612-3.
100. Bernardos A, Aznar E, Coll C, et al. Controlled release of vitamin B-2 using mesoporous materials functionalized with amine-bearing gate-like scaffoldings. J Control Release 2008; 131: 181-9.
101. Song S-W, Hidajat K, Kawi S. pH-controllable drug release using hydrogel encapsulated mesoporous silica. Chem Commun 2007; 4396-8.
102. Gao Q, Xu Y, Wu D, Sun Y, Li X. pH-Responsive drug release from polymer-coated mesoporous silica spheres. J Phys Chem C 2009; 113: 12753-8.
103. Park HS, Kim CW, Lee HJ, et al. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery. Nanotechnology 2010; 21: 225101 (9 pp).
104. Yang Q, Wang S, Fan P, et al. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem Mater 2005; 17: 5999-6003.
105. Wu J, Sailor M. Chitosan hydrogel-capped porous sio2 as a ph responsive nano-valve for triggered release of insulin. Adv Funct Mater 2009; 19: 733-41.
106. Khashab NM, Belowich ME, Trabolsi A, et al. pH-responsive mechanised nanoparticles gated by semirotaxanes. Chem Commun 2009; 5371-3.
107. Liu R, Zhang Y, Zhao X, Agarwal A, Mueller LJ, Feng P. pHResponsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. J Am Chem Soc 2010; 132: 1500-1.
108. Lai C-Y, Trewyn BG, Jeftinija DM, et al. A mesoporous silica nanosphere-based carrier system with chemically removable cds nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003; 125: 4451-9.
109. Torney F, Trewyn BG, Lin VS-Y, Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nature Nanotechnol 2007; 2: 295-300.
110. Aznar E, Marcos MD, Martinez-Máñez R, et al. pH- and photoswitched release of guest molecules from mesoporous silica supports. J Am Chem Soc 2009; 131: 6833-43.
111. Giri S, Trewyn BG, Stellmaker MP, Lin VS-Y. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed 2005; 44: 5038-44.
112. Fujiwara M, Terashima S, Endo Y, Shiokawa K, Ohue H. Switching catalytic reaction conducted in pore void of mesoporous material by redox gate control. Chem Commun 2006; 4635-7.
113. Liu R, Zhao X, Wu T, Feng P. Tunable redox-responsive hybrid nanogated ensembles. J Am Chem Soc 2008; 130: 14418-9.
114. Zhu C-L, Song X-Y, Zhou W-H, Yang H-H, Wen Y-H, Wang X-R. An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates. J Mater Chem 2009; 19; 7765-70.
115. Patel K, Angelos S, Dichtel WR, et al. Enzyme-responsive snap-top covered silica nanocontainers. J Am Chem Soc 2008; 130: 2382-3.
116. Park C, Kim H, Kim S, Kim C. Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests. J Am Chem Soc 2009; 131: 16614-5.
117. Schlossbauer A, Kecht J, Bein T. Biotin-avidin as a proteaseresponsive cap system for controlled guest release from colloidal mesoporous silica. Angew Chem Int Ed 2009; 48: 3092-5.
118. Climent E, Bernardos A, Martinez-Manez R, et al. controlled delivery systems using antibody-capped mesoporous nanocontainers. J Am Chem Soc 2009; 131: 14075-80.
119. Liu J, Jiang X, Ashley C, Brinker CJ. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. J Am Chem Soc 2009; 131: 7567-9.
120. Oyewumi MO, Rice K.G. In: Nanoparticle Technology for Drug Delivery; Gupta RB, Kompella UB, Eds. New York: Taylor & Francis Group 2006; pp. 361.
121. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VS-Y. A polyamidoamine dendrimer-capped mesoporous silica nanospherebased gene transfection reagent. J Am Chem Soc 2004; 126: 13216-7.
122. Park IY, Kim IY, Yoo MK, Choi YJ, Cho M-H, Cho CS. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Int J Pharm 2008; 359: 280-7.
123. Hom C, Lu J, Liong M, et al. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small 2010; 6: 1185-90.
124. Yu J, Zhao H, Ye L, et al. Effect of surface functionality of magnetic silica nanoparticles on the cellular uptake by glioma cells in vitro. J Mater Chem 2009; 19: 1265-70.
125. Lin MM, Kim H-H, Kim H, Dobson J, Kim DK. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy. Nanomedicine 2010; 5: 109-33.
126. Lu C-W, Hung Y, Hsiao J-K, et al. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 2007; 7: 149.
127. Lin Y-S, Wu S-H, Hung Y, et al. Multifunctional composite nanoparticles: magnetic, luminescent, and mesoporous. Chem Mater 2006; 18: 5170-2.
128. Liu H-M, Wu S-H, Lu C-W, et al. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. Small 2008; 4: 619-26.
129. Wu S-H, Lin Y-S, Hung Y, et al. Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic resonance imaging studies. Chem Bio Chem 2008; 9: 53-7.
130. Lin Y-S, Hung Y, Su J-K, et al. Gadolinium(III)-incorporated nanosized mesoporous silica as potential magnetic resonance imaging contrast agents. J Phys Chem B 2004; 108: 15608-11.
131. Taylor K-M, Kim J-S, Reiter W-J, An H, Lin W, Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J Am Chem Soc 2008; 130: 2154-5.
132. Hsiao J-K, Tsai C-P, Chung T-H, et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 2008; 4: 1445-52.
133. Carniato F, Tei L, Dastrù W, Marchese L, Botta M. Relaxivity modulation in Gd-functionalised mesoporous silicas. Chem Commun 2009; 1246.
134. Lin Y-S, Tsai C-P, Huang H-Y, et al. Well-ordered mesoporous silica nanoparticles as cell markers. Chem Mater 2005; 17: 4570-3.
135. Huang D-M, Hung Y, Ko B-S, et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J 2005; 19: 2014-6.
136. Lee C-H, Cheng S-H, Wang Y-J, et al. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater 2009; 19: 215-22.
137. Liong M, Lu J, Kovochich M, et al. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery. ACS Nano 2008; 2: 889-96.
138. Lee J-E, Lee N, Kim H, et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc 2010; 132: 552-7.
139. Chung T-H, Wu S-H, Yao M, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007; 28: 2959-66.
140. Lu F, Wu S-H, Hung Y, Mou C-Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009; 5: 1408-13.
141. Vallhov H, Gabrielsson S, Strømme M, Scheynius A, Garcia-Bennett A-E. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett 2007; 7: 3576-82.
142. Fisichella M, Dabboue H, Bhattacharyya S, et al. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicology in vitro 2009; 23: 697.
143. Trewyn B-G, Slowing I-I, Giri S, Chen H-T, Lin V S-Y. synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res 2007; 40: 846-53.
144. Di Pasqua A-J, Sharma K-K, Shi Y-L, et al. Cytotoxicity of mesoporous silica nanomaterials. J Inorg Biochem 2008; 102: 1416-23.
145. Tao Z, Toms BB, Goodisman J, Asefa T. Mesoporosity and Functional Group Dependent Endocytosis and Cytotoxicity of Silica Nanomaterials. Chem Res Toxicol 2009; 22: 1869-80.
146. Rosenholm JM, Sahlgren C, Lindén M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles - opportunities & challenges. Nanoscale 2010; 2: 1870-83.
147. Hudson SP, Padera RF, Langer R, Kohane DS. The biocompatibility of mesoporous silicates. Biomaterials 2008; 29: 4045-55.
148. Cho M, Cho WS, Choi M, et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 2009; 189: 177-83.
149. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005; 5: 161-71.
150. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7: 771-82.
151. Wei Y, Dong H, Xu J, Feng Q. Simultaneous Immobilization of Horseradish Peroxidase and Glucose Oxidase in Mesoporous Sol- Gel Host Materials. ChemPhysChem 2002; 3: 802-8.
152. Dai Z, Liu S, Ju H, Chen H. Direct electron transfer and enzymatic activity of hemoglobin in a hexagonal mesoporous silica matrix. Biosens Bioelectron 2004; 19: 861-7.
153. Dai ZH, Xu XX, Ju HX. Direct electrochemistry and electrocatalysis of myoglobin immobilized on a hexagonal mesoporous silica matrix. Anal Biochem 2004; 332: 23-31.
154. Radu DR, Lai CY, Wiench JW, Pruski M, Lin VS. Gatekeeping layer effect: a poly(lactic acid)-coated mesoporous silica nanosphere- based fluorescence probe for detection of amino-containing neurotransmitters. J Am Chem Soc 2004; 126: 1640-1.
155. Descalzo AB, Marcos MD, Monte C, Martínez-Máñez R, Rurack K. Mesoporous silica materials with covalently anchored phenoxazinone dyes as fluorescent hybrid materials for vapour sensing. J Mater Chem 2007; 44: 4716-23.
156. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007; 3: 1341-6.
157. Vivero-Escoto JL, Slowing II, Wu C-W, Lin VS-Y. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc 2009; 131: 3462-3.
158. Lu J, Liong M, Sherman S, et al. Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells. Nanobiotechnol 2007; 3: 89-95.
159. De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res 2000; 17: 113-26.
160. Dai C, Yuan Y, Liu C, et al. Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control. Biomaterials 2009: 30; 5364-74.
161. Mellaerts R, Mols R, Jammaer JAG, et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur J Pharm Biopharm 2008; 69: 223.
162. Brevet D, Gary-Bobo M, Raehm L, et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun 2009; 1475-7.
163. Gu J, Fan W, Shimojima A, Okubo T. Organic-inorganic mesoporous nanocarriers integrated with biogenic ligands. Small 2007; 3: 1740-4.
164. Slowing I, Trewyn BG, Lin VS-Y. Effect of Surface Functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 2006; 128: 14792-3.
165. Rosenholm JM, Meinander A, Peuhu E, et al. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano, 2009; 3: 197-206.
166. Tsai C-P, Chen C-Y, Hung Y, Chang F-H, Mou C-Y. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem 2009; 19: 5737-43.
167. Tu H-L, Lin Y-S, Lin H-Y, et al. In vitro studies of functionalized mesoporous silica nanoparticles for photodynamic therapy. Adv Mater 2009; 21: 172-4.
168. Cheng SH, Lee C-H, Yang C-S, Tseng F-G, Mou C-Y, Lo L-W. Mesoporous silica nanoparticles functionalized with an oxygensensing probe for cell photodynamic therapy: potential cancer theranostics J Mater Chem 2009; 19: 1252-7.